Question 1

Does ProShare Advisors own NVCR stock?

Accepted Answer

Yes. As of its Q3 2026 13F, ProShare Advisors holds 17,470 shares of NVCR (NovoCure), worth $278,646.

Question 2

How many shares of NVCR does ProShare Advisors own?

Accepted Answer

As of its Q3 2026 13F, ProShare Advisors holds 17,470 shares of NVCR (NovoCure).

Question 3

What is ProShare Advisors' NVCR position worth?

Accepted Answer

As of its Q3 2026 13F, ProShare Advisors' NVCR position is worth $278,646.

Question 4

Is ProShare Advisors buying or selling NVCR?

Accepted Answer

In Q3 2026, ProShare Advisors reduced its NVCR position by 333 shares (-1.9%).

Question 5

When did ProShare Advisors first buy NVCR?

Accepted Answer

ProShare Advisors already held NVCR in its Q4 2018 13F, the earliest on record, and has listed it in 28 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q3 Latest	Decreased	17,470	-1.9%	$278,646	0.0%	$15.95	0
2026-Q2	Decreased	17,803	-10.2%	$269,715	0.0%	$15.15	0
2026-Q1	Decreased	19,820	-15.6%	$216,039	0.0%	$10.90	0
2025-Q4	Increased	23,493	+10.0%	$303,765	0.0%	$12.93	26
2025-Q3	Decreased	21,357	-14.6%	$275,932	0.0%	$12.92	0
2025-Q2	Decreased	24,998	-10.8%	$444,964	0.0%	$17.80	0
2025-Q1	Decreased	28,013	-20.2%	$499,192	0.0%	$17.82	0
2024-Q4	Increased	35,115	+32.4%	$1M	0.0%	$29.80	32
2024-Q3	New	26,519	—	$414,493	0.0%	$15.63	33